These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 10158461)

  • 21. Nonprescription medicine use in a multiple sclerosis clinic population.
    Tremlett HL; Wiles CM; Luscombe DK
    Br J Clin Pharmacol; 2000 Jul; 50(1):55-60. PubMed ID: 10886119
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Druggists and pharmacists as gatekeepers: sales routines and compliance with sales protocols for over-the-counter naproxen 275 mg medicines in the Netherlands.
    van Hoof JJ; Cents MH; Megens NM; van der Tang SJ
    Health Policy; 2014 Sep; 117(3):353-60. PubMed ID: 25106069
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pattern of medication selling and self-medication practices: A study from Punjab, Pakistan.
    Aziz MM; Masood I; Yousaf M; Saleem H; Ye D; Fang Y
    PLoS One; 2018; 13(3):e0194240. PubMed ID: 29566014
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Changing the rules: coverage of nonprescription drugs.
    Navarro RP
    Med Interface; 1997 Feb; 10(2):84-6. PubMed ID: 10164796
    [No Abstract]   [Full Text] [Related]  

  • 25. Pharmacovigilance amongst patent medicine vendors (PMVs) in Ekiti state, Nigeria.
    Awodele O; Adeniran A; Awodele DF
    Int J Risk Saf Med; 2012; 24(2):65-72. PubMed ID: 22751188
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Drug Shop Intervention to Enhance Knowledge, Attitude, and Practices of Patent Medicine Vendors for the Control of COVID-19 In Southeastern Nigeria.
    Chukwuocha UM; Iwuoha GN; Ashinze OF; Njoku PU; Obasi CC; Adey EI; Dozie INS
    Am J Trop Med Hyg; 2021 Jun; 105(2):387-394. PubMed ID: 34148028
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Supply chain management of health commodities for reducing global disease burden.
    Chukwu OA; Ezeanochikwa VN; Eya BE
    Res Social Adm Pharm; 2017; 13(4):871-874. PubMed ID: 27720436
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Mothers' perception of recovery and satisfaction with patent medicine dealers' treatment of childhood febrile conditions in rural communities.
    Ibeneme GC; Nwaneri AC; Ibeneme SC; Ezenduka P; Strüver V; Fortwengel G; Okoye IJ
    Malar J; 2016 Jun; 15():336. PubMed ID: 27352902
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Impact of the reclassification of omeprazole on the prescribing and sales of ulcer healing drugs.
    Dhippayom T; Walker R
    Pharm World Sci; 2006 Aug; 28(4):194-8. PubMed ID: 17066243
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Dunkel proposals and the medical profession.
    Roy UK
    J Indian Med Assoc; 1993 Nov; 91(11):295-6. PubMed ID: 8138655
    [No Abstract]   [Full Text] [Related]  

  • 31. Why is the pharmaceutical industry investing increasing amounts in health economic evaluations?
    Andersson F
    Int J Technol Assess Health Care; 1995; 11(4):750-61. PubMed ID: 8567207
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Practical application of the charter of pharmaceutical sales visit].
    Leroy B; Uhart M; Lajoinie A; Maire P; Ducher M; Bourguignon L
    Ann Pharm Fr; 2012 Nov; 70(6):348-52. PubMed ID: 23177561
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Practices toward presumptive tuberculosis clients among patent medicine vendors in Ebonyi State Nigeria.
    Onah CK; Azuogu BN; Ossai EN; Agu AP; Ogbonnaya LU; Onwasigwe C
    Int J Mycobacteriol; 2021; 10(1):71-78. PubMed ID: 33707375
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Over-the-counter sales of statins and other drugs for asymptomatic conditions.
    Tinetti ME
    N Engl J Med; 2008 Jun; 358(25):2728-32. PubMed ID: 18565867
    [No Abstract]   [Full Text] [Related]  

  • 35. Social support in the practices of informal providers: The case of patent and proprietary medicine vendors in Nigeria.
    Sieverding M; Liu J; Beyeler N
    Soc Sci Med; 2015 Oct; 143():17-25. PubMed ID: 26331864
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Primary care training for patent medicine vendors in rural Nigeria.
    Oshiname FO; Brieger WR
    Soc Sci Med; 1992 Dec; 35(12):1477-84. PubMed ID: 1485195
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pharmaceuticals and Medical Devices: Cost Savings.
    Steiner DJ;
    Issue Brief Health Policy Track Serv; 2017 Dec; 2017():1-31. PubMed ID: 29361657
    [No Abstract]   [Full Text] [Related]  

  • 38. Haggling for a patent: what a government would have to pay for prescription drug patents.
    Guell RC
    Health Econ; 1997; 6(2):179-85. PubMed ID: 9158969
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Long way down--pharmaceutical companies fear falling off 'patent cliff'.
    Sklan A
    Pharm Pat Anal; 2012 Jul; 1(3):240. PubMed ID: 24386667
    [No Abstract]   [Full Text] [Related]  

  • 40. [Advertisements in newspapers and magazines about patent medicines in the Meiji era (The first dissertation) (Part 2)].
    Amano H; Kawabuchi M; Obana Y; Sugihara M
    Yakushigaku Zasshi; 1995; 30(2):140-4. PubMed ID: 11613528
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.